After all the money involved... I really think we should be more cautious with new drugs. Here in Brazil almost every cardiologist is prescribing aliskiren combined with ARB for diabetic patients who can pay for it. We have seen an absurd amount of propaganda here and Novartis is/was financing lots of congresses, journals, parties, travels, etc
After all the money involved... I really think we should be more cautious with new drugs. Here in Brazil almost every cardiologist is prescribing aliskiren combined with ARB for diabetic patients who can pay for it. We have seen an absurd amount of propaganda here and Novartis is/was financing lots of congresses, journals, parties, travels, etc